169 related articles for article (PubMed ID: 23122022)
1. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy.
Wong JW; Heller MM; Murase JE
Dermatol Online J; 2012 Oct; 18(10):15. PubMed ID: 23122022
[TBL] [Abstract][Full Text] [Related]
2. Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach.
Millsop JW; Heller MM; Murase JE
Dermatol Ther; 2013; 26(4):347-53. PubMed ID: 23914892
[TBL] [Abstract][Full Text] [Related]
3. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
Murase JE; Heller MM; Butler DC
J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
[TBL] [Abstract][Full Text] [Related]
4. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.
Schirm E; Meijer WM; Tobi H; de Jong-van den Berg LT
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):182-8. PubMed ID: 15140513
[TBL] [Abstract][Full Text] [Related]
5. The use of dermatologic drugs in pregnancy and lactation.
Leachman SA; Reed BR
Dermatol Clin; 2006 Apr; 24(2):167-97, vi. PubMed ID: 16677965
[TBL] [Abstract][Full Text] [Related]
6. Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.
Wesley BD; Sewell CA; Chang CY; Hatfield KP; Nguyen CP
Am J Obstet Gynecol; 2021 Jul; 225(1):21-32. PubMed ID: 34215352
[TBL] [Abstract][Full Text] [Related]
7. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.
Butler DC; Heller MM; Murase JE
J Am Acad Dermatol; 2014 Mar; 70(3):417.e1-10; quiz 427. PubMed ID: 24528912
[TBL] [Abstract][Full Text] [Related]
8. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
9. A practical guide to dermatological drug use in pregnancy.
Zip C
Skin Therapy Lett; 2006 May; 11(4):1-4. PubMed ID: 16732394
[TBL] [Abstract][Full Text] [Related]
10. Prescription of teratogenic medications in United States ambulatory practices.
Schwarz EB; Maselli J; Norton M; Gonzales R
Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacologic treatment of depression during pregnancy.
Gold LH
Curr Womens Health Rep; 2003 Jun; 3(3):236-41. PubMed ID: 12734035
[TBL] [Abstract][Full Text] [Related]
12. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
[TBL] [Abstract][Full Text] [Related]
13. Use and safety of antipsychotic drugs during pregnancy.
Einarson A; Boskovic R
J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
[TBL] [Abstract][Full Text] [Related]
14. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?
Law R; Bozzo P; Koren G; Einarson A
Can Fam Physician; 2010 Mar; 56(3):239-41. PubMed ID: 20228306
[TBL] [Abstract][Full Text] [Related]
15. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
[TBL] [Abstract][Full Text] [Related]
16. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
[No Abstract] [Full Text] [Related]
17. Dermatologic drugs, pregnancy, and lactation. A conservative guide.
Reed BR
Arch Dermatol; 1997 Jul; 133(7):894-8. PubMed ID: 9236528
[TBL] [Abstract][Full Text] [Related]
18. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
19. Drugs in pregnancy.
Koren G; Pastuszak A; Ito S
N Engl J Med; 1998 Apr; 338(16):1128-37. PubMed ID: 9545362
[No Abstract] [Full Text] [Related]
20. Exposure to attention deficit hyperactivity disorder medications during pregnancy.
Humphreys C; Garcia-Bournissen F; Ito S; Koren G
Can Fam Physician; 2007 Jul; 53(7):1153-5. PubMed ID: 17872810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
